Nos publications
Mise à jour août 2024
Pagination
- Page précédente
- Page 2
- Page suivante
Title | Authors | Year Trier par ordre croissant | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Améliorer la sécurité du traitement par IgIV pour les patients | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Blood.ca website | View Améliorer la sécurité du traitement par IgIV pour les patients | General public | Other |
Improving blood safety through a risk-informed approach to complex decision-making | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Blood.ca website | View Improving blood safety through a risk-informed approach to complex decision-making | General public | Other |
Antagonism of the Platelet-Activating Factor Pathway Mitigates Inflammatory Adverse Events Driven by Anti-erythrocyte Antibody Therapy in Mice | Won KD, Gil Gonzalez L, Cruz-Leal Y, Pavon Oro A, Lazarus AH | 2024 | J Immunol | View Antagonism of the Platelet-Activating Factor Pathway Mitigates Inflammatory Adverse Events Driven by Anti-erythrocyte Antibody Therapy in Mice | Researchers | Basic research |
Pushing the boundaries of hematopoietic stem cell transplantation: insights from cutting-edge preclinical research | Hasan T, Maganti HB | 2024 | Blood.ca website | View Pushing the boundaries of hematopoietic stem cell transplantation: insights from cutting-edge preclinical research | General public | Other |
Estimated median density identifies donor age and sex differences in red blood cell biological age | Mykhailova O, Brandon-Coatham M, Durand K, Olafson C, Xu A, Yi Q-L, Kanias T, Acker JP | 2024 | Transfusion | View Estimated median density identifies donor age and sex differences in red blood cell biological age | Researchers | Basic research |
Améliorer la sécurité et préserver les ressources en diminuant les transfusions inappropriées | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Blood.ca website | View Améliorer la sécurité et préserver les ressources en diminuant les transfusions inappropriées | General public | Other |
Understanding immunity in Canada: COVID-19 seroprevalence studies | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Blood.ca website | View Understanding immunity in Canada: COVID-19 seroprevalence studies | General public | Other |
Improving safety and conserving resources by reducing unnecessary transfusions | Canadian Blood Services' Innovation & Portfolio Management | 2024 | Blood.ca website | View Improving safety and conserving resources by reducing unnecessary transfusions | General public | Other |
Use of Intravenous Albumin: A Guideline From the International Collaboration for Transfusion Medicine Guidelines | Callum J, Skubas NJ, Bathla A, Keshavarz H, Clark EG, Rochwerg B, Fergusson D, Arbous S, Bauer SR, China L, Fung M, Jug R, Neill M, Paine C, Pavenski K, Shah PS, Robinson S, Shan H, Szczepiorkowski ZM, Thevenot T, Wu B, Stanworth S, Shehata N | 2024 | Chest | View Use of Intravenous Albumin: A Guideline From the International Collaboration for Transfusion Medicine Guidelines | Health care providers | Benchmarking and standard setting |
Lessons learned from the CONCOR-1 trial | Callum J, Bégin P, Jamula E, Liu Y, Kron AT, Auclair MC, Cushing M, Arnold DM | 2023 | Transfus Med | View Lessons learned from the CONCOR-1 trial | Researchers | Clinical research |
Hemocompatibility of bCyclodextrin-Modified (Methacryloyloxy)ethyl Phosphorylcholine Coated Magnetic Nanoparticles | Li S, Sharaf MG, Rowe EM, Serrano K, Devine DV, Unsworth LD | 2023 | Biomolecules | View Hemocompatibility of bCyclodextrin-Modified (Methacryloyloxy)ethyl Phosphorylcholine Coated Magnetic Nanoparticles | Researchers | Basic research |
Q&A: Anemia in Hospitalized Patients | Siegal D, Callum J, Sztainert T | 2023 | Blood.ca website | View Q&A: Anemia in Hospitalized Patients | Health care providers | Clinical research |
Comparing two extracellular additives to facilitate extended storage of red blood cells in a supercooled state | William N, Isiksacan Z, Mykhailova O, Olafson C, Yarmush ML, Usta OB, Acker JP | 2023 | Front Physiol | View Comparing two extracellular additives to facilitate extended storage of red blood cells in a supercooled state | Researchers | Basic research |
Evaluating the inventory impact of utilizing low titer platelets in regional hospitals | Blake JT, Clarke G, Bodnar M, Stepien J | 2023 | Transfusion | View Evaluating the inventory impact of utilizing low titer platelets in regional hospitals | Blood operators | Benchmarking and standard setting |
An evaluation of the clinical impacts of 7-day platelets | Ning S, Gabarin N, Li N, Liu Y, Lucier K, Barty R, Acker J, Webert KE, Warkentin TE, Arnold DM, Heddle NM | 2023 | Transfusion | View An evaluation of the clinical impacts of 7-day platelets | Researchers | Clinical research |
Validation Plan for Lower Volume Blood tubes | Siegal D, Callum J, Sztainert T | 2023 | Blood.ca website | View Validation Plan for Lower Volume Blood tubes | Health care providers | Benchmarking and standard setting |
Malattia emolitica del neonato (HDN): malattia di Rhesus (Rh) e MEN da altri anticorpi non-ABO | International Collaboration for Transfusion Medicine Guidelines | 2023 | ICTMG.org | View Malattia emolitica del neonato (HDN): malattia di Rhesus (Rh) e MEN da altri anticorpi non-ABO | General public | Other |
Desialylated Platelet Clearance in the Liver is a Novel Mechanism of Systemic Immunosuppression | Li J, Karakas D, Xue F, Chen Y, Zhu G, Yucel YH, MacParland SA, Zhang H, Semple JW, Freedman J, Shi Q, Ni H | 2023 | Research | View Desialylated Platelet Clearance in the Liver is a Novel Mechanism of Systemic Immunosuppression | Researchers | Basic research |
Transfusion medicine education delivery in Rwanda: Adapting Transfusion Camp to a resource-limited setting | Skelton T, Nizeyimana F, Pendergrast J, Hagumimana J, Masaisa F, Kanyamuhunga A, Gashaija C, Callum J, Pavenski K, Khandelwal A, Lieberman L, Chargé S, Kapitany C, Morgan M, Meirovich H, Lin Y | 2023 | Transfusion | View Transfusion medicine education delivery in Rwanda: Adapting Transfusion Camp to a resource-limited setting | Health care providers | Education research |
Alternatives to blood donor deferral of gay, bisexual, and other men who have sex with men: Acceptability of screening the sexual risk behavior of all blood donors | Fisher WA, Kohut T, Woo H, Haw J | 2023 | Transfusion | View Alternatives to blood donor deferral of gay, bisexual, and other men who have sex with men: Acceptability of screening the sexual risk behavior of all blood donors | Blood operators | MSM research |
Prophylaxis use of clotting factor replacement products in people with non-severe haemophilia: A review of the literature | Iorio A, Königs C, Reding MT, Rotellini D, Skinner MW, Mancuso ME, Berntorp E | 2023 | Haemophilia | View Prophylaxis use of clotting factor replacement products in people with non-severe haemophilia: A review of the literature | Health care providers | Clinical research |
Cross-Canada Variability in Blood Donor SARS-CoV-2 Seroprevalence by Social Determinants of Health | O’Brien SF, Caffrey N, Yi Q-L, Bolotin S, Janjua NZ, Binka M, Thanh CQ, Stein DR, Lang A, Colquhoun A, Pambrun C, Reedman CN, Drews SJ | 2023 | Microbiol Spectr | View Cross-Canada Variability in Blood Donor SARS-CoV-2 Seroprevalence by Social Determinants of Health | Researchers | Clinical research |
Evaluating variation in perioperative red blood cell transfusion for patients undergoing elective gastrointestinal cancer surgery | Zuckerman J, Coburn N, Callum J, Mahar AL, Lin Y, Turgeon AF, McLeod R, Pearsall E, Martel G, Hallet J | 2023 | Surgery | View Evaluating variation in perioperative red blood cell transfusion for patients undergoing elective gastrointestinal cancer surgery | Researchers | Clinical research |
Innovation & Portfolio Management Annual Impact Report 2022 – 2023 | Canadian Blood Services' Innovation & Portfolio Management | 2023 | Blood.ca website | View Innovation & Portfolio Management Annual Impact Report 2022 – 2023 | General public | Other |
Granulocyte transfusion therapy | Gardner E, Fernandes M, Latour C, Seftel M, Acker J, Clarke G | 2023 | Clinical Guide to Transfusion | View Granulocyte transfusion therapy | Health care providers | Benchmarking and standard setting |
Leveraging Donor Populations to Study the Epidemiology and Pathogenesis of Transfusion-Transmitted and Emerging Infectious Diseases | Bloch EM, Busch MP, Corash LM, Dodd R, Hailu B, Kleinman S, O'Brien S, Petersen L, Stramer SL, Katz L | 2023 | Transfus Med Rev | View Leveraging Donor Populations to Study the Epidemiology and Pathogenesis of Transfusion-Transmitted and Emerging Infectious Diseases | Researchers | New or improved product or process |
International Forum on Blood Donation in Individuals with Current, Past or Germline Predisposition to Malignancy: Summary | Baggio D, Fox LC, Wood EM, Aditya RN, Goldman M, van den Berg K, Kayser S, Wuchter P, Namba N, Tsuno NH, Makino S, Lee CK, Akhtar N, Shah F, Miflin G, Prati D, La Raja M, La Rocca U, Richard P, Tiberghien P, Harley RJ, Raouf MY, Sharma R, Kaur S, Bruijns S, Prakke-Weekamp H, Dunbar N | 2023 | Vox Sang | View International Forum on Blood Donation in Individuals with Current, Past or Germline Predisposition to Malignancy: Summary | Blood operators | Benchmarking and standard setting |
Medication use in Canadian blood donors | Goldman M, Miller O, O'Brien SF | 2023 | Vox Sang | View Medication use in Canadian blood donors | Blood operators | Clinical research |
FAQ : plasma traité au solvant-détergent (Octaplasma) | Mack J, Gordon I, Romans R, Webert K, Ning S, Zeller M | 2023 | Blood.ca website | View FAQ : plasma traité au solvant-détergent (Octaplasma) | Health care providers | New or improved product or process |
Circular of information for the use of human blood components: Plasma Components | Stewart T | 2023 | Blood.ca website | View Circular of information for the use of human blood components: Plasma Components | Health care providers | Benchmarking and standard setting |
First Report of Successful Laser Warming for Frozen Gonadal Tissues and Oocytes in the Domestic Cat Model | Rowlison T, Nagashima J, Acker J, Ben R, Daly J, Hagedorn, Comizzoli P | 2023 | Biopreserv Biobank | View First Report of Successful Laser Warming for Frozen Gonadal Tissues and Oocytes in the Domestic Cat Model | Researchers | Basic research |
Emotional Labor of Nurses and Phlebotomists in a New Source Plasma Collection Site During the COVID-19 Pandemic | Holloway K | 2023 | Glob Qual Nurs Res | View Emotional Labor of Nurses and Phlebotomists in a New Source Plasma Collection Site During the COVID-19 Pandemic | Researchers | Ethical, legal & social implications research |
Perivascular niche cells sense thrombocytopenia and activate hematopoietic stem cells in an IL-1 dependent manner | Luis TC, Barkas N, Carrelha J, Giustacchini A, Mazzi S, Norfo R, Wu B, Aliouat A, Guerrero JA, Rodriguez-Meira A, Bouriez-Jones T, Macaulay IC, Jasztal M, Zhu G, Ni H, Robson MJ, Blakely RD, Mead AJ, Nerlov C, Ghevaert C, Jacobsen SEW | 2023 | Nat Commun | View Perivascular niche cells sense thrombocytopenia and activate hematopoietic stem cells in an IL-1 dependent manner | Researchers | Basic research |
HLA-haplotype redundancy and rareness in Canadian Blood Services' Stem Cell Registry and Cord Blood Bank: Novel metrics for optimizing utility | Bailey AJM, Blake J, Ganz K, Seftel MD, Allan DS | 2023 | Transfusion | View HLA-haplotype redundancy and rareness in Canadian Blood Services' Stem Cell Registry and Cord Blood Bank: Novel metrics for optimizing utility | Blood operators | Benchmarking and standard setting |
Humoral and Cellular Response of Transplant Recipients to a Third Dose of mRNA SARS-CoV-2 Vaccine: A Systematic Review and Meta-analysis | Bailey AJM, Maganti HB, Cheng W, Shorr R, Arianne Buchan C, Allan DS | 2023 | Transplantation | View Humoral and Cellular Response of Transplant Recipients to a Third Dose of mRNA SARS-CoV-2 Vaccine: A Systematic Review and Meta-analysis | Researchers | Basic research |
A Survey of Patient Experience in CML: American and Canadian Perspectives | Hillis C, Flynn KE, Goldman EH, Moreira-Lucas TS, Visentini J, Dorman S, Ballinger R, Byrnes HF, De Palma A, Barbier V, Machado L, Atallah E | 2023 | Patient Prefer Adherence | View A Survey of Patient Experience in CML: American and Canadian Perspectives | Researchers | Clinical research |
Improved access yet inequitable experience: gay, bisexual and other men who have sex with men’s views of more inclusive criteria for source plasma donation | Vesnaver E, Butler-Foster T, Goldman M, Gibson E, Palumbo A, Lapierre D, Hill NE, MacDonagh R, Rubini KA, Bridel W, Miguel G, Rosser A, MacPherson P, Randall T, Osbourne-Sorrell W, O’Brien SF, Otis J, Greaves M, Al-Bakri TB, Germain M, Orvis S, Clapperton AT, Reid M, Labrecque M, Devine D, Presseau J | 2023 | BMC Public Health | View Improved access yet inequitable experience: gay, bisexual and other men who have sex with men’s views of more inclusive criteria for source plasma donation | Blood operators | MSM research |
Malattia emolitica del neonato (MEN): incompatibilità ABO | International Collaboration for Transfusion Medicine Guidelines | 2023 | ICTMG.org | View Malattia emolitica del neonato (MEN): incompatibilità ABO | General public | Other |
SARS-CoV-2 RBD and Its Variants Can Induce Platelet Activation and Clearance: Implications for Antibody Therapy and Vaccinations against COVID-19 | Ma X, Liang J, Zhu G, Bhoria P, Shoara AA, MacKeigan DT, Khoury CJ, Slavkovic S, Lin L, Karakas D, Chen Z, Prifti V, Liu Z, Shen C, Li Y, Zhang C, Dou J, Rousseau Z, Zhang J, Ni T, Lei X, Chen P, Wu X, Shaykhalishahi H, Mubareka S, Connelly KA, Zhang H, Rotstein O, Ni H | 2023 | Research | View SARS-CoV-2 RBD and Its Variants Can Induce Platelet Activation and Clearance: Implications for Antibody Therapy and Vaccinations against COVID-19 | Researchers | Clinical research |
Unexpected difficulty in performance of a monocyte monolayer assay when using RBCs from a patient with sickle cell disease | Lipman T, Bienz MN, Pendergrast J, Cserti-Gazdewich C, Branch DR | 2023 | Transfusion | View Unexpected difficulty in performance of a monocyte monolayer assay when using RBCs from a patient with sickle cell disease | Researchers | Basic research |
Thymic stromal lymphopoietin induces platelet mitophagy and promotes thrombosis in Kawasaki disease | Fu L, MacKeigan DT, Gong Q, Che D, Xu Y, Pi L, Sun C, Yu H, Chen K, Zhou H, Jiang Z, Wang Z, Zhang L, Cerenzia EG, Ni H, Gu X | 2023 | Brit J Haem | View Thymic stromal lymphopoietin induces platelet mitophagy and promotes thrombosis in Kawasaki disease | Researchers | Clinical research |
Transfusion Camp: Successes and challenges in scaling and expanding a transfusion medicine education program | Lin Y, Khandelwal A, Kapitany C, Chargé S | 2023 | Transfus Apher Sci | View Transfusion Camp: Successes and challenges in scaling and expanding a transfusion medicine education program | Health care providers | Education research |
Prevalence of selected bleeding and thrombotic events in persons with hemophilia versus the general population: A scoping review | Shapiro AD, Hardesty BM, Peyvandi F, Iorio A | 2023 | Res Pract Thromb Haemost | View Prevalence of selected bleeding and thrombotic events in persons with hemophilia versus the general population: A scoping review | Researchers | Clinical research |
Whole Blood and Apheresis Collection of Blood Components Intended for Transfusion | Acker JP, Razatos A, Marks D | 2023 | AABB Technical Manual, 21st Edition | View Whole Blood and Apheresis Collection of Blood Components Intended for Transfusion | Researchers | Benchmarking and standard setting |
Medication Deferrals in Blood Donors | Goldman M, Jacquot C, Land K | 2023 | Transfus Med Rev | View Medication Deferrals in Blood Donors | Blood operators | Clinical research |
International Forum on Management of Blood Donors with Culture-Positive Platelet Donations: Summary | Vassallo R, Kamel H, Goel R, Al-Riyami AZ, Al Muharrmi Z, Jacquot C, Ramirez-Arcos S, Khandelwal A, Goldman M, Hands K, McLintock L, Mitchell H, Wendel S, Scuracchio P, Fachini R, Pettersson SM, Bengtsson J, Brailsford SR, Tossell J, Amorim L, Lopes ME, Pêcego M, Germain M, Renaud C, Morley SL, So R, Townsend M, Hopkins C, Harritshoej LH, Erikstrup C, Gosbell IB, Levin MH, Dennington PM, Dunbar N | 2023 | Vox Sang | View International Forum on Management of Blood Donors with Culture-Positive Platelet Donations: Summary | Blood operators | Benchmarking and standard setting |
FAQ: Solvent detergent (S/D) treated plasma (Octaplasma) | Mack J, Gordon R, Romans R, Webert K, Ning S, Zeller M | 2023 | Blood.ca website | View FAQ: Solvent detergent (S/D) treated plasma (Octaplasma) | Health care providers | New or improved product or process |
Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques | Stewart T | 2023 | Blood.ca website | View Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques | Health care providers | Benchmarking and standard setting |
Loss of Autophagy Activity during Storage of Hematopoietic Stem Cell Grafts Is Associated with Reduced Potency | Maganti H, Jahan S, Patel J, Kaushal R, McGregor C, Pasha R, Pineault N | 2023 | Blood | View Loss of Autophagy Activity during Storage of Hematopoietic Stem Cell Grafts Is Associated with Reduced Potency | Researchers | Basic research |
Rapport d’impact annuel 2022-2023 Innovation et gestion du portefeuille | Canadian Blood Services' Innovation & Portfolio Management | 2023 | Blood.ca website | View Rapport d’impact annuel 2022-2023 Innovation et gestion du portefeuille | General public | Other |